In the study, company researchers explored treating corn rootworms with RNAi molecules that would interfere with the viability of their offspring.
Editas will earn an upfront payment of $25 million to launch three research programs to apply CRISPR/Cas9 and TALEN genome editing to Juno's immunotherapies.
The bodies will assemble an international committee to guide future research and have planned a summit this fall for experts to discuss the implications of the technology.
Commercial software packages with a suite of additional features offer an alternative to academic guide RNA design tools for CRISPR/Cas9 genome editing.
High-throughput, systematic screens found 25 protein domains essential to AML, including six that are already drug targets in clinical trials.
In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.
The New York Times editorial board weighs in on scientific research misconduct.
The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.
The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.